![]() Clinical report from the pilot USA kernicterus registry (1992 to 2004). Johnson L, Bhutani VK, Karp K, Sivieri EM, Shapiro SM. Primary care interventions to support breastfeeding: updated evidence report and systematic review for the US preventive services task force. Patnode CD, Henninger ML, Senger CA, Perdue LA, Whitlock EP. Primary prevention of cow’s milk sensitization and food allergy by avoiding supplementation with cow’s milk formula at birth: a randomized clinical trial. Metaanalysis of effects of exclusive breastfeeding on infant gut microbiota across populations. Efficacy of subthreshold newborn phototherapy during the birth hospitalization in preventing readmissions for phototherapy. ![]() Wickremasinghe AC, Kuzniewicz MW, McCulloch CE, Newman TB. Early weight loss nomograms for exclusively breastfed newborns. Flaherman VJ, Schaefer EW, Kuzniewicz MW, Li SX, Walsh EM, Paul IM. Rockville, MD: Breastfeeding Uptake, and Maternal Health Outcomes in Developed Countries 2018Ģ1. ![]() Feltner C, Weber RP, Stuebe A, Grodensky CA, Orr C, Viswanathan M. Meek JY, Noble L American Academy of Pediatrics, Section on Breastfeeding. The natural history of jaundice in predominantly breastfed infants. Effect of breast-feeding frequency on hyperbilirubinemia in breast-fed term neonate. Maternal anti-D prophylaxis during pregnancy does not cause neonatal haemolysis. Maayan-Metzger A, Schwartz T, Sulkes J, Merlob P. Coordinating care across the perinatal continuum in hemolytic disease of the fetus and newborn: the timely handoff of a positive maternal anti-erythrocyte antibody screen. 181 summary: prevention of Rh D alloimmunization. ABM clinical protocol #22: guidelines for management of jaundice in the breastfeeding infant 35 weeks or more of gestation -revised. Flaherman VJ, Maisels MJ Academy of Breastfeeding Medicine. NCNC hyperbilirubinemia treatment guideline. Technical report: Diagnosis and management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Slaughter JL, Kemper AR, Newman TB, et al. Reduction of severe hyperbilirubinemia after institution of predischarge bilirubin screening. Incidence, etiology, and outcomes of hazardous hyperbilirubinemia in newborns. Kuzniewicz MW, Wickremasinghe AC, Wu YW, et al. The effect of instituting a pre hospital-discharge newborn bilirubin screening program in an 18-hospital health system. Eggert LD, Wiedmeier SE, Wilson J, Christensen RD. Kernicterus: epidemiological strategies for its prevention through systems-based approaches. Bhutani VK, Johnson LH, Jeffrey Maisels M, et al. Hyperbilirubinemia in the newborn infant > or 35 weeks’ gestation: an update with clarifications. Maisels MJ, Bhutani VK, Bogen D, Newman TB, Stark AR, Watchko JF. Classifying recommendations for clinical practice guidelines. American Academy of Pediatrics Steering Committee on Quality Improvement and Management. In: Volpe J, Inder T, Barras D, et al, eds. Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Maisels MJ, Baltz RD, Bhutani VK, et al American Academy of Pediatrics Subcommittee on Hyperbilirubinemia. ![]() Predischarge screening for severe neonatal hyperbilirubinemia infants who need phototherapy. Bhutani VK, Stark AR, Lazzeroni LC, et al Initial Clinical Testing Evaluation and Risk Assessment for Universal Screening for Hyperbilirubinemia Study Group. Visual assessment of jaundice in term and late preterm infants.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |